Phase I Study of TAS-106 in Combo With Carboplatin

NCT00752011 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Solid Tumors

Interventions

DRUG: TAS-106
DRUG: Carboplatin

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]